Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-02-01
2008-09-16
Spector, Lorraine (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388150, C530S388220, C530S387300, C530S391300, C424S130100, C435S007200, C435S007100, C435S069100, C435S070210, C436S501000
Reexamination Certificate
active
07425622
ABSTRACT:
The present invention relates to antibodies and related molecules that specifically bind to C3a Receptor. Such antibodies have uses, for example, in the prevention and treatment of asthma, allergy, and other related inflammatory and immune disorders. The invention also relates to nucleic acid molecules encoding anti-C3a Receptor antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially inflammatory and other related disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to C3a Receptor.
REFERENCES:
patent: 6342220 (2002-01-01), Adams et al.
patent: WO-02/002641 (2002-08-01), None
Therien et al. Agonist activity of the small molecule C3aR ligand SB290157. J Immunol., 174, 7479-7480, 2005.
Fruehauf et al., Innovative strategies for PBPC mobilization. Cytotherapy, 7, 438-446, 2005.
Reca et al., Functional receptor for C3a anaphylatoxin is exxpressed by normal hematopoietic stem/ progenitor cells, and C3a enhances their homing-relateed responses to SDF-1. Blood, 101, 3784-3793, 2003.
Griffiths, et al., “Human anti-self antibodies with high specificity from phage-display libraries,”Embo J., 12:725-734 (1993).
Marks, et al., “By-passing Immunization: Human antibodies from V-gene libraries displayed on phage,”J. Mol. Biol., 222:581-597 (1991).
Marriette, et al., “Nucleotide sequence analysis of the variable domains of four human monoclonal IgM with an antibody activity to myelin-associated glycoprotein,”Eur. J. Immunol., 23:846-851 (1993).
Mortari, et al., “The human cord blood antibody repertoirs. Frequent usage of the Vh7 gene family,”Eur. J. Immunology, 22:241-245 (1992).
Raaphorst, et al., “Restricted utilization of germ-line Vh3 genes and the diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobin heavy chain rearrangements,”Eur. J. Immunology, 22:247-251 (1992).
Tomlison, et al., “The repertolre of human germline Vh sequences reveals about fifty groups of Vh segments with different hypervariable loops,”J. Mol. Biol., 227:776-798 (1992).
Wu, et al., “Myosin-reactive autoantibodies in rheumatic carditis and normal fetus,”Clin. Immunol. Immunopathol., 87:184-192 (1998).
Human Genome Sciences Inc.
Spector Lorraine
Stoica Elly-Gerald
LandOfFree
Antibodies against C3a receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against C3a receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against C3a receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983657